Authors:
WOODS KL
KETLEY D
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROWICZ A
REIKVAM A
SCHILLING J
SEABRAGOMES R
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., USE OF CORONARY ANGIOGRAPHY AND REVASCULARIZATION PROCEDURES FOLLOWING ACUTE MYOCARDIAL-INFARCTION - A EUROPEAN PERSPECTIVE, European heart journal, 19(9), 1998, pp. 1348-1354
Authors:
WOODS KL
KETLEY D
LOWY A
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROWICZ A
REIKVAM A
SCHILLING J
SEABRAGOMES R
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., BETA-BLOCKERS AND ANTITHROMBOTIC TREATMENT FOR SECONDARY PREVENTION AFTER ACUTE MYOCARDIAL-INFARCTION - TOWARDS AN UNDERSTANDING OF FACTORSINFLUENCING CLINICAL-PRACTICE, European heart journal, 19(1), 1998, pp. 74-79
Authors:
MARTINEZ M
AGUSTI A
ARNAU JM
VIDAL X
LAPORTE JR
Citation: M. Martinez et al., TRENDS OF PRESCRIBING PATTERNS FOR THE SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION OVER A 13-YEAR PERIOD, European Journal of Clinical Pharmacology, 54(3), 1998, pp. 203-208
Authors:
LLOP R
FERRER A
AGUSTI A
VIDAL X
ARNAU JM
LAPORTE JR
Citation: R. Llop et al., FROM CLINICAL-TRIALS TO CLINICAL-PRACTICE - ORAL ANTICOAGULATION AMONG PATIENTS WITH NONRHEUMATIC, ATRIAL-FIBRILLATION, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 1-5
Citation: E. Cucurull et al., PRESCRIPTION OF ANTICOAGULANT-THERAPY TO PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 75-75
Citation: C. Aguilera et al., THE INFLUENCE OF A THERAPEUTIC CONSULTATION SERVICE ON CLINICAL DECISIONS, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 83-83
Authors:
WOODS KL
KETLEY D
AGUSTI A
HAGN C
KALA R
KARATZAS NB
LEIZOROVICZ A
LOWY A
REIKVAM A
SCHILLING J
GOMES RS
VASILIAUSKAS D
WILHELMSEN L
Citation: Kl. Woods et al., TRANSLATION OF CLINICAL-TRIALS INTO PRACTICE - A EUROPEAN POPULATION-BASED STUDY OF THE USE OF THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION, Lancet, 347(9010), 1996, pp. 1203-1207
Citation: A. Agusti et al., CLINICAL-TRIALS VERSUS CLINICAL-PRACTICE IN THE SECONDARY PREVENTION SF MYOCARDIAL-INFARCTION, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 95-99